Through this subsidiary, the company has developed multiple proprietary Medical Cannabis research technologies to collect and analyze research data from our patient studies. This data will prove the efficacy of medical cannabis treatment.
Once proven this same technology will allow us to continually track and collect active patient data.
The company’s software securely stores patient information and tracks the results of the research for each patient using mobile devices, remote medical monitoring devices and mobile applications.
The company’s goal is to enroll up to 500,000 patients.